Patient Groups Warn HHS Against Weakening Protected Drug Classes

By John Wilkerson / February 26, 2021 at 2:43 PM
Nearly 140 patient groups are urging the Biden administration to block an 11th-hour Trump-era policy change to let drug plans ignore Medicare protections of some of the most vulnerable patients, and the head of the HIV+Hepatitis Policy Institute warned of litigation if the administration doesn’t block the policy. Patient lobbyists were given some hope when the Biden HHS postponed a Feb. 3 webinar for plans interested in participating in a demonstration that would waive patient protections, but the solicitation for...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.